ArticleHuman vaccines & immunotherapeutics2018

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine.

Scott B HalsteadPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.